Lapsi Health B.V.

Lapsi Health is developing the new generation of digital biomarkers based on auscultatory sound. The data used as a biomarker has to be quantifiable and objective and the company’s novel technology greatly enhances its usage in medicine, relating it to the health-disease process for prognostic, diagnostic and therapeutic purposes.

Lapsi Health's logo
  • Category: Medtech
  • Customer segment: B2B
  • Development stage: On market
  • Funding stage: Series A
  • Founding year: 2022
  • Team members: 6

Lapsi Health is developing the new generation of digital biomarkers based on auscultatory sound. The data used as a biomarker has to be quantifiable and objective and the company’s novel technology greatly enhances its usage in medicine, relating it to the health-disease process for prognostic, diagnostic and therapeutic purposes.

 

    • Founding year: 2022
    • Development phase: Prototype/beta testing
    • Funding stage: Pre-seed/Seed
    • Contact person info: info(at)lapsihealth.com
    • Team members: 6

Would you like to give feedback on this page?

Enabling the usage of statistics cookies will allow you to share your input.